All stock lists
Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
Healthcare · Biotechnology
13.83-0.26 (-1.85%)
Insider Score
––Not scored
IOVA Insider Score
Insiders here have filed 16 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
IOVA analyst forecast
IOVA analyst consensus
No analyst ratings in the last 3 months.
IOVA 12-month price target
$11.83-13.8% downsideaverage of 6 firms
$20.00High
$2.00Low
Best analysts covering IOVA
No firm covering IOVA has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
IOVA analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| Barclays | — | $18.00 | +23.6% | — | 2026-10-13 | |
| Wells Fargo | — | $18.00 | +24.6% | — | 2026-09-30 | |
| H.C. Wainwright | — | $20.00 | +42.2% | — | 2026-09-29 | |
| UBS | — | $7.00 | -12.4% | — | 2026-08-20 | |
| Robert W. Baird | — | $6.00 | -3.4% | — | 2026-08-07 | |
| Goldman Sachs | — | $2.00 | -18.0% | — | 2026-02-05 | |
| UBS | — | $2.00 | +20.5% | — | 2025-05-16 | |
| Piper Sandler | — | $7.50 | +28.2% | — | 2025-01-31 | |
| UBS | — | $17.00 | +73.1% | — | 2024-10-24 | |
| Stifel Nicolaus | — | $23.00 | +479.3% | — | 2024-08-09 | |
| Robert W. Baird | — | $24.00 | +504.5% | — | 2024-08-09 | |
| Piper Sandler | — | $10.00 | +8.1% | — | 2024-07-29 | |
| JMP Securities | — | $23.00 | +475.0% | — | 2024-06-20 | |
| Stifel Nicolaus | — | $28.00 | +530.6% | — | 2024-05-31 | |
| Piper Sandler | — | $19.00 | +33.7% | — | 2024-03-14 | |
| Goldman Sachs | — | $6.00 | -16.3% | — | 2022-12-08 | |
| Piper Sandler | — | $11.00 | +66.2% | — | 2022-11-20 | |
| Robert W. Baird | — | $25.00 | +334.8% | — | 2022-08-23 | |
| Robert W. Baird | — | $34.00 | +86.5% | — | 2022-04-07 | |
| Robert W. Baird | — | $30.00 | +81.2% | — | 2022-04-05 | |
| Stifel Nicolaus | — | $25.00 | +66.2% | — | 2022-01-28 | |
| Wells Fargo | — | $25.00 | +48.6% | — | 2022-01-05 | |
| Barclays | — | $40.00 | +144.9% | — | 2021-05-19 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.